Intestinal Perforation Secondary to Bortezomib-Induced Autonomic Neuropathy

被引:0
作者
Salas, Jose Antonio Sanchez [1 ]
Belmonte, Maria Jose Moreno [1 ]
Garcia, Andrea Poveda [1 ]
Ruiz, Estela Ruiz [1 ]
Espejo, Eva Soler [1 ]
Perianes, Valentin Cabanas [1 ]
Hernandez, Ana Maria Garcia [1 ]
机构
[1] Virgen Arrixaca Univ Hosp, Dept Hematol, Murcia, Spain
关键词
Bortezomib; Intestinal perforation; Intestinal Pseudo-obstruction; multiple myeloma; peripheral neuropathies; PARALYTIC ILEUS;
D O I
10.1002/ccr3.70340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is essential to evaluate both the patient's prior conditions and the severity of the current clinical presentation when deciding on BTZ toxicity management. It seems prudent to consider the permanent discontinuation of the drug in patients who have experienced at least grade 3 intestinal neuropathy and have structural abnormalities or other risk factors for intestinal perforation.Trial Registration: NCT03710603
引用
收藏
页数:4
相关论文
共 17 条
[1]   Bortezomib-induced peripheral neurotoxicity: an update [J].
Argyriou, Andreas A. ;
Cavaletti, Guido ;
Bruna, Jordi ;
Kyritsis, Athanasios P. ;
Kalofonos, Haralabos P. .
ARCHIVES OF TOXICOLOGY, 2014, 88 (09) :1669-1679
[2]   TOXIC MEGACOLON LEADING TO BOWEL PERFORATION: A RARE ADVERSE EFFECT OF BORTEZOMIB [J].
Bhalla, Varun ;
Niu, Chengu ;
Gill, Prabhsimrat ;
Mulkareddy, Vani ;
Sitaraman, Karthikeyan .
CHEST, 2023, 164 (04) :1525A-1526A
[3]   High Incidence of Paralytic Ileus After Bortezomib Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients: Report of 2 Cases [J].
De Sousa-Amorim, Erika ;
Revuelta, Ignacio ;
Diekmann, Fritz ;
Cofan, Frederic ;
Cid, Joan ;
Lozano, Miquel ;
Maria Campistol, Josep ;
Oppenheimer, Federic .
TRANSPLANTATION, 2015, 99 (11) :E170-E171
[4]  
European Medicines Agency, 2009, Velcade: EPAR Product Information
[5]  
European Myeloma Network BV, A Phase 3 Study Comparing Daratumumab, Velcade (Bortezomib), Lenalidomide, and Dexamethasone (DVRd) vs. Velcade, Lenalidomide, and Dexamethasone (VRd) in Subjects With Previously Untreated Multiple Myeloma Who Are Eligible for HighDose Therapy
[6]   Velcade®:: USFDA approval for the treatment of multiple myeloma progressing on prior therapy [J].
Kane, RC ;
Bross, PF ;
Farrell, AT ;
Pazdur, R .
ONCOLOGIST, 2003, 8 (06) :508-513
[7]  
Keating Matthew, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-217000
[8]   Paralytic ileus following "subcutaneous bortezomib" therapy: focus on the clinical emergency-report of two cases [J].
Mele, Giuseppe ;
Coppi, Maria Rosaria ;
Melpignano, Angela ;
Quarta, Giovanni .
CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (01) :99-101
[9]   Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in-class anticancer moteasome inhibitor [J].
Perfetti, Vittorio ;
Palladini, Giovanni ;
Brunetti, Laura ;
Sgarella, Adele ;
Brugnatelli, Silvia ;
Gobbi, Paolo G. ;
Corazza, Gino Roberto .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (07) :599-601
[10]   2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation [J].
Pisano, Michele ;
Zorcolo, Luigi ;
Merli, Cecilia ;
Cimbanassi, Stefania ;
Poiasina, Elia ;
Ceresoli, Marco ;
Agresta, Ferdinando ;
Allievi, Niccolo ;
Bellanova, Giovanni ;
Coccolini, Federico ;
Coy, Claudio ;
Fugazzola, Paola ;
Martinez, Carlos Augusto ;
Montori, Giulia ;
Paolillo, Ciro ;
Penachim, Thiago Jose ;
Pereira, Bruno ;
Reis, Tarcisio ;
Restivo, Angelo ;
Rezende-Neto, Joao ;
Sartelli, Massimo ;
Valentino, Massimo ;
Abu-Zidan, Fikri M. ;
Ashkenazi, Itamar ;
Bala, Miklosh ;
Chiara, Osvaldo ;
de' Angelis, Nicola ;
Deidda, Simona ;
De Simone, Belinda ;
Di Saverio, Salomone ;
Finotti, Elena ;
Kenji, Inaba ;
Moore, Ernest ;
Wexner, Steven ;
Biffl, Walter ;
Coimbra, Raul ;
Guttadauro, Angelo ;
Leppaniemi, Ari ;
Maier, Ron ;
Magnone, Stefano ;
Mefire, Alain Chicom ;
Peitzmann, Andrew ;
Sakakushev, Boris ;
Sugrue, Michael ;
Viale, Pierluigi ;
Weber, Dieter ;
Kashuk, Jeffry ;
Fraga, Gustavo P. ;
Kluger, Ioran ;
Catena, Fausto .
WORLD JOURNAL OF EMERGENCY SURGERY, 2018, 13